WHO (ed.): Therapeutics and COVID-19: Living guideline (WHO/2019-nCoV/therapeutics/2022.3), Geneva (April 22, 2022), online in: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2022.3. Licence: CC BY-NC-SA 3.0 IGO.
The WHO Therapeutics and COVID-19: Living guideline contains the organization’s most current recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format and through an online platform, and is updated regularly as new evidence becomes available.
This tenth version of the WHO guideline contains 17 recommendations, including two new recommendations on nirmatrelvir-ritonavir. No further updates have been made to existing recommendations in this latest version.